PR Newswire BiotechOriginal article
uMotif to Showcase Modern eConsent and eCOA Platform to Bolster the Pivotal Patient-Site Relationship in Clinical Trials at Life Sciences Events
ConferencePositive
AI Analysis
Summary
uMotif will showcase its eConsent and eCOA platform at life sciences events, highlighting its consumer-grade technology for clinical trial participants and sites. The announcement features remarks from company leadership including CEO Andrea Valente and other executives.
Importance:2/10
Sentiment:
0.30
digital healthclinical trialseConsenteCOApatient engagement
Read the original article
Published by PR Newswire Biotech on September 10, 2026 11:00 AM
